ClinicalTrials.gov
public full text
Public Domain
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection#1161746
- Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma#863779
- Therapeutic Zinc in Childhood Pneumonia#1060120
- Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children#881446
- Effect of Heliox on RSV Bronchiolitis#909282
Record · ID 847401
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive